Skip to main content
PMC home page
Journal of Virology logoLink to Journal of Virology
. 1991 Dec;65(12):6597–6603. doi: 10.1128/jvi.65.12.6597-6603.1991

N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state.

B Caughey 1, G J Raymond 1, D Ernst 1, R E Race 1
PMCID: PMC250721  PMID: 1682507

Abstract

Scrapie and related transmissible spongiform encephalopathies result in the accumulation of a protease-resistant form of an endogenous brain protein called PrP. As an approach to understanding the scrapie-associated modification of PrP, we have studied the processing and sedimentation properties of protease-resistant PrP (PrP-res) in scrapie-infected mouse neuroblastoma cells. Like brain-derived PrP-res, the neuroblastoma cell PrP-res aggregated in detergent lysates, providing evidence that the tendency to aggregate is an intrinsic property of PrP-res and not merely a secondary consequence of degenerative brain pathology. The PrP-res species had lower apparent molecular masses than the normal, protease-sensitive PrP species and were not affected by moderate treatments with proteinase K. This suggested that the PrP-res species were partially proteolyzed by the neuroblastoma cells. Immunoblot analysis of PrP-res with a panel of monospecific anti-PrP peptide sera confirmed that the PrP-res species were quantitatively truncated at the N terminus. The metabolic labeling of PrP-res in serum-free medium did not prevent the proteolysis of PrP-res, showing that the protease(s) involved was cellular rather than serum-derived. The PrP-res truncation was inhibited in intact cells by leupeptin and NH4Cl. This provided evidence that a lysosomal protease(s) was involved, and therefore, that PrP-res was translocated to lysosomes. When considered with other studies, these results imply that the conversion of PrP to the protease-resistant state occurs in the plasma membrane or along an endocytic pathway before PrP-res is exposed to endosomal and lysosomal proteases.

Full text

PDF
6597

Images in this article

6599Image
on p.6599
6599Image
on p.6599
6600Image
on p.6600
6601Image
on p.6601
6601Image
on p.6601

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alper T., Cramp W. A., Haig D. A., Clarke M. C. Does the agent of scrapie replicate without nucleic acid? Nature. 1967 May 20;214(5090):764–766. doi: 10.1038/214764a0. [DOI] [PubMed] [Google Scholar]
  2. Basler K., Oesch B., Scott M., Westaway D., Wälchli M., Groth D. F., McKinley M. P., Prusiner S. B., Weissmann C. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell. 1986 Aug 1;46(3):417–428. doi: 10.1016/0092-8674(86)90662-8. [DOI] [PubMed] [Google Scholar]
  3. Beaven G. H., Gratzer W. B., Davies H. G. Formation and structure of gels and fibrils from glucagon. Eur J Biochem. 1969 Nov;11(1):37–42. doi: 10.1111/j.1432-1033.1969.tb00735.x. [DOI] [PubMed] [Google Scholar]
  4. Bendheim P. E., Barry R. A., DeArmond S. J., Stites D. P., Prusiner S. B. Antibodies to a scrapie prion protein. Nature. 1984 Aug 2;310(5976):418–421. doi: 10.1038/310418a0. [DOI] [PubMed] [Google Scholar]
  5. Bolton D. C., Bendheim P. E., Marmorstein A. D., Potempska A. Isolation and structural studies of the intact scrapie agent protein. Arch Biochem Biophys. 1987 Nov 1;258(2):579–590. doi: 10.1016/0003-9861(87)90380-8. [DOI] [PubMed] [Google Scholar]
  6. Bolton D. C., McKinley M. P., Prusiner S. B. Identification of a protein that purifies with the scrapie prion. Science. 1982 Dec 24;218(4579):1309–1311. doi: 10.1126/science.6815801. [DOI] [PubMed] [Google Scholar]
  7. Bolton D. C., Meyer R. K., Prusiner S. B. Scrapie PrP 27-30 is a sialoglycoprotein. J Virol. 1985 Feb;53(2):596–606. doi: 10.1128/jvi.53.2.596-606.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Borchelt D. R., Scott M., Taraboulos A., Stahl N., Prusiner S. B. Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells. J Cell Biol. 1990 Mar;110(3):743–752. doi: 10.1083/jcb.110.3.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Braig H. R., Diringer H. Scrapie: concept of a virus-induced amyloidosis of the brain. EMBO J. 1985 Sep;4(9):2309–2312. doi: 10.1002/j.1460-2075.1985.tb03931.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Brown P., Coker-Vann M., Pomeroy K., Franko M., Asher D. M., Gibbs C. J., Jr, Gajdusek D. C. Diagnosis of Creutzfeldt-Jakob disease by Western blot identification of marker protein in human brain tissue. N Engl J Med. 1986 Feb 27;314(9):547–551. doi: 10.1056/NEJM198602273140904. [DOI] [PubMed] [Google Scholar]
  11. Butler D. A., Scott M. R., Bockman J. M., Borchelt D. R., Taraboulos A., Hsiao K. K., Kingsbury D. T., Prusiner S. B. Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins. J Virol. 1988 May;62(5):1558–1564. doi: 10.1128/jvi.62.5.1558-1564.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Caughey B. W., Dong A., Bhat K. S., Ernst D., Hayes S. F., Caughey W. S. Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry. 1991 Aug 6;30(31):7672–7680. doi: 10.1021/bi00245a003. [DOI] [PubMed] [Google Scholar]
  13. Caughey B. In vitro expression and biosynthesis of prion protein. Curr Top Microbiol Immunol. 1991;172:93–107. doi: 10.1007/978-3-642-76540-7_6. [DOI] [PubMed] [Google Scholar]
  14. Caughey B., Race R. E., Ernst D., Buchmeier M. J., Chesebro B. Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells. J Virol. 1989 Jan;63(1):175–181. doi: 10.1128/jvi.63.1.175-181.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Caughey B., Race R. E., Vogel M., Buchmeier M. J., Chesebro B. In vitro expression in eukaryotic cells of a prion protein gene cloned from scrapie-infected mouse brain. Proc Natl Acad Sci U S A. 1988 Jul;85(13):4657–4661. doi: 10.1073/pnas.85.13.4657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Caughey B., Raymond G. J. The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem. 1991 Sep 25;266(27):18217–18223. [PubMed] [Google Scholar]
  17. Chesebro B., Race R., Wehrly K., Nishio J., Bloom M., Lechner D., Bergstrom S., Robbins K., Mayer L., Keith J. M. Identification of scrapie prion protein-specific mRNA in scrapie-infected and uninfected brain. Nature. 1985 May 23;315(6017):331–333. doi: 10.1038/315331a0. [DOI] [PubMed] [Google Scholar]
  18. Cho H. J. Antibody to scrapie-associated fibril protein identifies a cellular antigen. J Gen Virol. 1986 Feb;67(Pt 2):243–253. doi: 10.1099/0022-1317-67-2-243. [DOI] [PubMed] [Google Scholar]
  19. Czub M., Braig H. R., Diringer H. Pathogenesis of scrapie: study of the temporal development of clinical symptoms, of infectivity titres and scrapie-associated fibrils in brains of hamsters infected intraperitoneally. J Gen Virol. 1986 Sep;67(Pt 9):2005–2009. doi: 10.1099/0022-1317-67-9-2005. [DOI] [PubMed] [Google Scholar]
  20. DeArmond S. J., McKinley M. P., Barry R. A., Braunfeld M. B., McColloch J. R., Prusiner S. B. Identification of prion amyloid filaments in scrapie-infected brain. Cell. 1985 May;41(1):221–235. doi: 10.1016/0092-8674(85)90076-5. [DOI] [PubMed] [Google Scholar]
  21. Diringer H., Blode H., Oberdieck U. Virus-induced amyloidosis in scrapie involves a change in covalent linkages in the preamyloid. Arch Virol. 1991;118(1-2):127–131. doi: 10.1007/BF01311308. [DOI] [PubMed] [Google Scholar]
  22. Diringer H., Gelderblom H., Hilmert H., Ozel M., Edelbluth C., Kimberlin R. H. Scrapie infectivity, fibrils and low molecular weight protein. Nature. 1983 Dec 1;306(5942):476–478. doi: 10.1038/306476a0. [DOI] [PubMed] [Google Scholar]
  23. Diringer H., Hilmert H., Simon D., Werner E., Ehlers B. Towards purification of the scrapie agent. Eur J Biochem. 1983 Aug 15;134(3):555–560. doi: 10.1111/j.1432-1033.1983.tb07602.x. [DOI] [PubMed] [Google Scholar]
  24. Gabizon R., McKinley M. P., Groth D., Prusiner S. B. Immunoaffinity purification and neutralization of scrapie prion infectivity. Proc Natl Acad Sci U S A. 1988 Sep;85(18):6617–6621. doi: 10.1073/pnas.85.18.6617. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Griffith J. S. Self-replication and scrapie. Nature. 1967 Sep 2;215(5105):1043–1044. doi: 10.1038/2151043a0. [DOI] [PubMed] [Google Scholar]
  26. Hare J. F., Huston M. Degradation of surface-labeled hepatoma membrane polypeptides: effect of inhibitors. Arch Biochem Biophys. 1984 Sep;233(2):547–555. doi: 10.1016/0003-9861(84)90478-8. [DOI] [PubMed] [Google Scholar]
  27. Hare J. F. Mechanisms of membrane protein turnover. Biochim Biophys Acta. 1990 Feb 28;1031(1):71–90. doi: 10.1016/0304-4157(90)90003-u. [DOI] [PubMed] [Google Scholar]
  28. Hope J., Morton L. J., Farquhar C. F., Multhaup G., Beyreuther K., Kimberlin R. H. The major polypeptide of scrapie-associated fibrils (SAF) has the same size, charge distribution and N-terminal protein sequence as predicted for the normal brain protein (PrP). EMBO J. 1986 Oct;5(10):2591–2597. doi: 10.1002/j.1460-2075.1986.tb04539.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Hope J., Multhaup G., Reekie L. J., Kimberlin R. H., Beyreuther K. Molecular pathology of scrapie-associated fibril protein (PrP) in mouse brain affected by the ME7 strain of scrapie. Eur J Biochem. 1988 Mar 1;172(2):271–277. doi: 10.1111/j.1432-1033.1988.tb13883.x. [DOI] [PubMed] [Google Scholar]
  30. Hyman C., Froehner S. C. Degradation of acetylcholine receptors in muscle cells: effect of leupeptin on turnover rate, intracellular pool sizes, and receptor properties. J Cell Biol. 1983 May;96(5):1316–1324. doi: 10.1083/jcb.96.5.1316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kelly R. B. Microtubules, membrane traffic, and cell organization. Cell. 1990 Apr 6;61(1):5–7. doi: 10.1016/0092-8674(90)90206-t. [DOI] [PubMed] [Google Scholar]
  32. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  33. Libby P., Bursztajn S., Goldberg A. L. Degradation of the acetylcholine receptor in cultured muscle cells: selective inhibitors and the fate of undegraded receptors. Cell. 1980 Feb;19(2):481–491. doi: 10.1016/0092-8674(80)90523-1. [DOI] [PubMed] [Google Scholar]
  34. Manuelidis L., Valley S., Manuelidis E. E. Specific proteins associated with Creutzfeldt-Jakob disease and scrapie share antigenic and carbohydrate determinants. Proc Natl Acad Sci U S A. 1985 Jun;82(12):4263–4267. doi: 10.1073/pnas.82.12.4263. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. McKinley M. P., Bolton D. C., Prusiner S. B. A protease-resistant protein is a structural component of the scrapie prion. Cell. 1983 Nov;35(1):57–62. doi: 10.1016/0092-8674(83)90207-6. [DOI] [PubMed] [Google Scholar]
  36. Merz P. A., Kascsak R. J., Rubenstein R., Carp R. I., Wisniewski H. M. Antisera to scrapie-associated fibril protein and prion protein decorate scrapie-associated fibrils. J Virol. 1987 Jan;61(1):42–49. doi: 10.1128/jvi.61.1.42-49.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Merz P. A., Somerville R. A., Wisniewski H. M., Manuelidis L., Manuelidis E. E. Scrapie-associated fibrils in Creutzfeldt-Jakob disease. Nature. 1983 Dec 1;306(5942):474–476. doi: 10.1038/306474a0. [DOI] [PubMed] [Google Scholar]
  38. Neary K., Caughey B., Ernst D., Race R. E., Chesebro B. Protease sensitivity and nuclease resistance of the scrapie agent propagated in vitro in neuroblastoma cells. J Virol. 1991 Feb;65(2):1031–1034. doi: 10.1128/jvi.65.2.1031-1034.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Oesch B., Westaway D., Wälchli M., McKinley M. P., Kent S. B., Aebersold R., Barry R. A., Tempst P., Teplow D. B., Hood L. E. A cellular gene encodes scrapie PrP 27-30 protein. Cell. 1985 Apr;40(4):735–746. doi: 10.1016/0092-8674(85)90333-2. [DOI] [PubMed] [Google Scholar]
  40. Pattison I. H., Jones K. M. The possible nature of the transmissible agent of scrapie. Vet Rec. 1967 Jan 7;80(1):2–9. doi: 10.1136/vr.80.1.2. [DOI] [PubMed] [Google Scholar]
  41. Prusiner S. B., McKinley M. P., Bowman K. A., Bolton D. C., Bendheim P. E., Groth D. F., Glenner G. G. Scrapie prions aggregate to form amyloid-like birefringent rods. Cell. 1983 Dec;35(2 Pt 1):349–358. doi: 10.1016/0092-8674(83)90168-x. [DOI] [PubMed] [Google Scholar]
  42. Prusiner S. B. Novel proteinaceous infectious particles cause scrapie. Science. 1982 Apr 9;216(4542):136–144. doi: 10.1126/science.6801762. [DOI] [PubMed] [Google Scholar]
  43. Race R. E., Caughey B., Graham K., Ernst D., Chesebro B. Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones. J Virol. 1988 Aug;62(8):2845–2849. doi: 10.1128/jvi.62.8.2845-2849.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Race R. E., Fadness L. H., Chesebro B. Characterization of scrapie infection in mouse neuroblastoma cells. J Gen Virol. 1987 May;68(Pt 5):1391–1399. doi: 10.1099/0022-1317-68-5-1391. [DOI] [PubMed] [Google Scholar]
  45. Race R. The scrapie agent in vitro. Curr Top Microbiol Immunol. 1991;172:181–193. doi: 10.1007/978-3-642-76540-7_12. [DOI] [PubMed] [Google Scholar]
  46. Roberts G. W., Lofthouse R., Brown R., Crow T. J., Barry R. A., Prusiner S. B. Prion-protein immunoreactivity in human transmissible dementias. N Engl J Med. 1986 Nov 6;315(19):1231–1233. doi: 10.1056/NEJM198611063151919. [DOI] [PubMed] [Google Scholar]
  47. Seglen P. O., Grinde B., Solheim A. E. Inhibition of the lysosomal pathway of protein degradation in isolated rat hepatocytes by ammonia, methylamine, chloroquine and leupeptin. Eur J Biochem. 1979 Apr 2;95(2):215–225. doi: 10.1111/j.1432-1033.1979.tb12956.x. [DOI] [PubMed] [Google Scholar]
  48. Seglen P. O. Inhibitors of lysosomal function. Methods Enzymol. 1983;96:737–764. doi: 10.1016/s0076-6879(83)96063-9. [DOI] [PubMed] [Google Scholar]
  49. Stahl N., Baldwin M. A., Burlingame A. L., Prusiner S. B. Identification of glycoinositol phospholipid linked and truncated forms of the scrapie prion protein. Biochemistry. 1990 Sep 25;29(38):8879–8884. doi: 10.1021/bi00490a001. [DOI] [PubMed] [Google Scholar]
  50. Stahl N., Borchelt D. R., Hsiao K., Prusiner S. B. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell. 1987 Oct 23;51(2):229–240. doi: 10.1016/0092-8674(87)90150-4. [DOI] [PubMed] [Google Scholar]
  51. Taraboulos A., Rogers M., Borchelt D. R., McKinley M. P., Scott M., Serban D., Prusiner S. B. Acquisition of protease resistance by prion proteins in scrapie-infected cells does not require asparagine-linked glycosylation. Proc Natl Acad Sci U S A. 1990 Nov;87(21):8262–8266. doi: 10.1073/pnas.87.21.8262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Taraboulos A., Serban D., Prusiner S. B. Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells. J Cell Biol. 1990 Jun;110(6):2117–2132. doi: 10.1083/jcb.110.6.2117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Turk E., Teplow D. B., Hood L. E., Prusiner S. B. Purification and properties of the cellular and scrapie hamster prion proteins. Eur J Biochem. 1988 Sep 1;176(1):21–30. doi: 10.1111/j.1432-1033.1988.tb14246.x. [DOI] [PubMed] [Google Scholar]
  55. Wiley C. A., Burrola P. G., Buchmeier M. J., Wooddell M. K., Barry R. A., Prusiner S. B., Lampert P. W. Immuno-gold localization of prion filaments in scrapie-infected hamster brains. Lab Invest. 1987 Dec;57(6):646–656. [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES